| http://www.w3.org/ns/prov#value | - Agent: Sheridan Ross PC20090088400 - Prostaglandin e2 modulation and uses thereof: Methods, uses, kits and products are described for the prognosis, diagnosis, prevention and treatment of myotronic dystrophy type 1 (DM1), and more particularly for the prognosis, diagnosis, prevention and treatment of the congenital form of myotronic dystrophy type 1 (cDM1), based on changes in/modulation of prosta
|
